Difference between revisions of "Journal Club"
From Bioinformatics Lab
Line 8: | Line 8: | ||
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/06/14 | |style="padding:.4em;" rowspan=2|2017/06/14 | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-36 |
|style="padding:.4em;"|HJ Han | |style="padding:.4em;"|HJ Han | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1126%2Fscience.aaf8399 Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy.] | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1126%2Fscience.aaf8399 Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy.] | ||
|- | |- | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-35 |
|style="padding:.4em;"|JW Cho | |style="padding:.4em;"|JW Cho | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 19: | Line 19: | ||
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/06/07 | |style="padding:.4em;" rowspan=2|2017/06/07 | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-34 |
|style="padding:.4em;"|JW Cho | |style="padding:.4em;"|JW Cho | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[http://biorxiv.org/content/early/2015/09/01/025908 The landscape of T cell infiltration in human cancer and its association with antigen presenting gene expression.] | [http://biorxiv.org/content/early/2015/09/01/025908 The landscape of T cell infiltration in human cancer and its association with antigen presenting gene expression.] | ||
|- | |- | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-33 |
|style="padding:.4em;"|KS Kim | |style="padding:.4em;"|KS Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 30: | Line 30: | ||
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/05/31 | |style="padding:.4em;" rowspan=2|2017/05/31 | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-32 |
|style="padding:.4em;"| | |style="padding:.4em;"| | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[http://www.tandfonline.com/doi/full/10.1080/2162402X.2016.1253654 Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.] | [http://www.tandfonline.com/doi/full/10.1080/2162402X.2016.1253654 Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.] | ||
|- | |- | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-31 |
|style="padding:.4em;"|MY Lee | |style="padding:.4em;"|MY Lee | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 41: | Line 41: | ||
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/05/24 | |style="padding:.4em;" rowspan=2|2017/05/24 | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-30 |
|style="padding:.4em;"|DS Bae | |style="padding:.4em;"|DS Bae | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.02.065 Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.] | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.02.065 Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.] | ||
|- | |- | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-29 |
|style="padding:.4em;"|MY Lee | |style="padding:.4em;"|MY Lee | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 52: | Line 52: | ||
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/05/17 | |style="padding:.4em;" rowspan=2|2017/05/17 | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-28 |
|style="padding:.4em;"|EB Kim | |style="padding:.4em;"|EB Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.12.022 Systemic Immunity Is Required for Effective Cencer Immunotherapy.] | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.12.022 Systemic Immunity Is Required for Effective Cencer Immunotherapy.] | ||
|- | |- | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-27 |
|style="padding:.4em;"|CY Kim | |style="padding:.4em;"|CY Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 63: | Line 63: | ||
|- | |- | ||
|style="padding:.4em;" rowspan=3|2017/05/10 | |style="padding:.4em;" rowspan=3|2017/05/10 | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-26 |
|style="padding:.4em;"| | |style="padding:.4em;"| | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.10.018 Host and Environmental Factors Influencing Individual Human Cytokine Responses.] | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.10.018 Host and Environmental Factors Influencing Individual Human Cytokine Responses.] | ||
|- | |- | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-25 |
|style="padding:.4em;"| | |style="padding:.4em;"| | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 74: | Line 74: | ||
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/04/26 | |style="padding:.4em;" rowspan=2|2017/04/26 | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-24 |
|style="padding:.4em;"| | |style="padding:.4em;"| | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038%2FNMETH.4177 Pooled CRISPR screening with single-cell transcriptome readout.] | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038%2FNMETH.4177 Pooled CRISPR screening with single-cell transcriptome readout.] | ||
|- | |- | ||
− | |style="padding:.4em;"|17- | + | |style="padding:.4em;"|17-23 |
|style="padding:.4em;"| | |style="padding:.4em;"| | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| |
Revision as of 17:47, 9 March 2017
2012
2011
2010